{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:27Z","timestamp":1791413307789,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,27]],"date-time":"2015-06-27T00:00:00Z","timestamp":1435363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00259-015-3068-8","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:44:53Z","timestamp":1435279493000},"page":"1718-1738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology"],"prefix":"10.1007","volume":"42","author":[{"given":"C.","family":"Chiesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maccauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Romito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Camerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pellizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bhoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Facciorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Civelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lanocita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Padovano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Migliorisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"De Nile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Seregni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,27]]},"reference":[{"key":"3068_CR1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26382","volume":"58","author":"R Salem","year":"2013","unstructured":"Salem R, Mazzaferro V, Sangro B. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Hepatology 2013;58:2188\u201397.","journal-title":"Hepatology"},{"key":"3068_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semnuclmed.2009.11.001","volume":"40","author":"H Ahmadzadehfar","year":"2010","unstructured":"Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med 2010;40:105\u201321.","journal-title":"Semin Nucl Med"},{"key":"3068_CR3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00259-013-2674-6","volume":"41","author":"C Spreafico","year":"2014","unstructured":"Spreafico C, Maccauro M, Mazzaferro V, Chiesa C. The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE). Eur J Nucl Med Mol Imaging 2014;41:634\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3068_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","volume":"369","author":"C Parker","year":"2013","unstructured":"Parker C, Nilsson S, Heinrich D, O\u2019Sullivan JM, Foss\u00e5 SD, Chodacki A, et al. Alpha emitter radium-223 and survival im metastatic prostate cancer. N Engl J Med 2013;369:213\u201323.","journal-title":"N Engl J Med"},{"key":"3068_CR5","unstructured":"clinicaltrials.gov keyword NETTER-1."},{"key":"3068_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fonc.2014.00210","volume":"4","author":"M Cremonesi","year":"2014","unstructured":"Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol 2014;4:210. doi: 10.3389\/fonc.2014.00210 .","journal-title":"Front Oncol"},{"key":"3068_CR7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","volume":"51","author":"L Strigari","year":"2010","unstructured":"Strigari L, Sciuto R, Rea S, Carpanese L, Pizzi G, Soriani A, et al. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations. J Nucl Med 2010;51:1377\u201385.","journal-title":"J Nucl Med"},{"key":"3068_CR8","first-page":"168","volume":"55","author":"C Chiesa","year":"2011","unstructured":"Chiesa C, Maccauro M, Romito C, Spreafico C, Pellizzari S, Negri A, et al. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Q J Nucl Med Mol Imaging 2011;55:168\u201397.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3068_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.113.126839","volume":"55","author":"S Walrand","year":"2014","unstructured":"Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F. The low hepatic toxicity per gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med 2014;55:135\u201340.","journal-title":"J Nucl Med"},{"key":"3068_CR10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/srao.2001.23485","volume":"11","author":"LA Dawson","year":"2001","unstructured":"Dawson LA, Ten Haken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol 2001;11:240\u20136.","journal-title":"Semin Radiat Oncol"},{"key":"3068_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semradonc.2005.04.005","volume":"15","author":"LA Dawson","year":"2005","unstructured":"Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005;15:279\u201383.","journal-title":"Semin Radiat Oncol"},{"key":"3068_CR12","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","volume":"57","author":"V Mazzaferro","year":"2013","unstructured":"Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocarcinoma: a phase 2 study. Hepatology 2013;57:1826\u201337.","journal-title":"Hepatology"},{"key":"3068_CR13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.1994.436","volume":"70","author":"WY Lau","year":"1994","unstructured":"Lau WY, Leung WT, Ho S, Leung NWY, Chan M, Lin J, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994;70:994\u20139.","journal-title":"Br J Cancer"},{"key":"3068_CR14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","volume":"23","author":"S Ho","year":"1996","unstructured":"Ho S, Lau WY, Leung TWT, Chan M, Ngar YK, Johnson PJ, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996;23:947\u201352.","journal-title":"Eur J Nucl Med"},{"key":"3068_CR15","doi-asserted-by":"crossref","unstructured":"Flamen P, Vanderlinde B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, et al. Corrigendum: Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres. Phys Med Biol 2008:53;6591\u2013603 (Erratum in Phys Med Biol 2014:59;2549\u201351). doi: 10.1088\/0031-9155\/59\/10\/2549 .","DOI":"10.1088\/0031-9155\/59\/10\/2549"},{"key":"3068_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.111.094235","volume":"53","author":"E Garin","year":"2012","unstructured":"Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 2012;53:255\u201363.","journal-title":"J Nucl Med"},{"key":"3068_CR17","doi-asserted-by":"crossref","unstructured":"Walrand S, Lhommel R, Goffette P, Van den Eynde M, Pauwels S, Jamar F. Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. EJNMMI Res 2012;2:20. http:\/\/www.ejnmmires.com\/content\/2\/1\/20 .","DOI":"10.1186\/2191-219X-2-20"},{"key":"3068_CR18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-013-2395-x","volume":"40","author":"E Garin","year":"2013","unstructured":"Garin E, Lenoir L, Edeline J, Laffont S, Mesbah H, Por\u00e9e P, et al. Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging 2013;40:1057\u201368. doi: 10.1007\/s00259-013-2395-x .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3068_CR19","first-page":"503","volume":"56","author":"C Chiesa","year":"2012","unstructured":"Chiesa C, Mira M, Maccauro M, Romito R, Spreafico C, Sposito C, et al. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres. Q J Nucl Med Mol Imaging 2012;56:503\u20138.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3068_CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00259-010-1549-3","volume":"38","author":"M Lassmann","year":"2011","unstructured":"Lassmann M, Chiesa C, Flux G, Bardi\u00e8s M, EANM Dosimetry Committee. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging 2011;38:192\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3068_CR21","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1118\/1.3608909","volume":"38","author":"WA Dezarn","year":"2011","unstructured":"Dezarn WA, Cessa JT, DeWerd LA, Feng W, Gates VL, Kennedy AS, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 2011;38:4824\u201345.","journal-title":"Med Phys"},{"key":"3068_CR22","doi-asserted-by":"crossref","unstructured":"Dale RG. Dose-rate effects in targeted radiotherapy. Phys Med Biol 1996;41:1871\u201384.","DOI":"10.1088\/0031-9155\/41\/10\/001"},{"key":"3068_CR23","unstructured":"Barone R, Borson-Chazot F, Valkema R, Walrand S, Chauvin F, Gogou L, et al. Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose\u2013effect relationship. J Nucl Med 2005;46:99S\u2013106."},{"key":"3068_CR24","first-page":"1337","volume":"40","author":"J O\u2019Donoghue","year":"1999","unstructured":"O\u2019Donoghue J. Implications of nonuniform tumor doses for radioimmunotherapy. J Nucl Med 1999;40:1337\u201341.","journal-title":"J Nucl Med"},{"key":"3068_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1088\/0031-9155\/45\/1\/311","volume":"45","author":"LC Jones","year":"2000","unstructured":"Jones LC, Hoban PW. Treatment plan comparison using equivalent uniform biologically effective dose (EUBED). Phys Med Biol 2000;45:159\u201370.","journal-title":"Phys Med Biol"},{"key":"3068_CR26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.coc.0000236210.41199.91","volume":"29","author":"S Krishnan","year":"2006","unstructured":"Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, et al. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 2006;29:562\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"3068_CR27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00259-008-0857-3","volume":"35","author":"M Cremonesi","year":"2008","unstructured":"Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aric\u00f2 D, et al. Radioembolization with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging 2008;35(11):2088\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"3068_CR28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0360-3016(94)00471-4","volume":"31","author":"A Jackson","year":"1995","unstructured":"Jackson A, Ten Haken RK, Robertson JM, Kessler ML, Kutcher GJ, Lawrence TS. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995;31(4):883\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3068_CR29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijrobp.2007.10.037","volume":"70","author":"A Tai","year":"2008","unstructured":"Tai A, Erickson B, Khater KA, Li XA. Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. Int J Radiat Oncol Biol Phys 2008;70:900\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3068_CR30","unstructured":"Agresti A, Coull BA. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. Am Stat 1998;52(2):119\u201326."},{"key":"3068_CR31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","volume":"8","author":"JT Lyman","year":"1985","unstructured":"Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13\u20139.","journal-title":"Radiat Res Suppl"},{"key":"3068_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1748-717X-6-61","volume":"6","author":"V Moiseenko","year":"2011","unstructured":"Moiseenko V, Song WY, Mell LK, Bhandare NA. Comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol 2011;6:61.","journal-title":"Radiat Oncol"},{"issue":"8","key":"3068_CR33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2967\/jnumed.113.135301","volume":"55","author":"S Walrand","year":"2014","unstructured":"Walrand S, Hesse M, Jamar F, Lhommel RA. A hepatic dose-toxicity model opening the way toward individualized radioembolization planning. J Nucl Med 2014;55(8):1317\u201322.","journal-title":"J Nucl Med"},{"key":"3068_CR34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","volume":"148","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839\u201343.","journal-title":"Radiology"},{"key":"3068_CR35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","volume":"53","author":"YK Dewaraja","year":"2012","unstructured":"Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, et al. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med 2012;53:1310\u201325.","journal-title":"J Nucl Med"},{"key":"3068_CR36","doi-asserted-by":"crossref","unstructured":"Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET\/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res 2013;3:57.","DOI":"10.1186\/2191-219X-3-57"},{"key":"3068_CR37","doi-asserted-by":"crossref","unstructured":"Pasciak AS, Bourgeois AC, Bradley YC. A comparison of techniques for (90)Y PET\/CT image-based dosimetry following radioembolization with resin microspheres. Front Oncol 2014;4:121. doi: 10.3389\/fonc.2014.00121 http:\/\/journal.frontiersin.org\/Journal\/ 10.3389\/fonc.2014.00121\/abstract .","DOI":"10.3389\/fonc.2014.00121"},{"key":"3068_CR38","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1088\/0031-9155\/60\/5\/1945","volume":"60","author":"M Pacilio","year":"2015","unstructured":"Pacilio M, Amato E, Lanconelli N, Basile C, Torres LA, Botta F, et al. Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECT. Phys Med Biol 2015;60:1945\u201364.","journal-title":"Phys Med Biol"},{"key":"3068_CR39","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","volume":"11","author":"B Fertil","year":"1985","unstructured":"Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699\u2013707.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3068_CR40","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","volume":"37","author":"MP Stokkel","year":"2010","unstructured":"Stokkel MP, Handkiewicz Junak D, Lassmann M, Dietlein M, Luster M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging 2010;37:2218\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"3068_CR41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198310203091601","volume":"309","author":"HR Maxon","year":"1983","unstructured":"Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309(16):937\u201341.","journal-title":"N Engl J Med"},{"key":"3068_CR42","first-page":"313","volume":"43","author":"HR Maxon","year":"1999","unstructured":"Maxon HR. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 1999;43:313\u201323.","journal-title":"Q J Nucl Med"},{"key":"3068_CR43","doi-asserted-by":"crossref","unstructured":"Sgouros G, Hobbs RF. Patient-specific dosimetry, radiobiology, and the previously-treated patient. In: Medical radiology. Radiation oncology. New York: Springer; 2012.","DOI":"10.1007\/174_2012_684"},{"key":"3068_CR44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2967\/jnumed.112.112508","volume":"54","author":"G Ulrich","year":"2013","unstructured":"Ulrich G, Dudeck O, Furth C, Ruf J, Grosser OS, Adolf D, et al. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. J Nucl Med 2013;54:516\u201322.","journal-title":"J Nucl Med"},{"issue":"7","key":"3068_CR45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2967\/jnumed.113.129361","volume":"55","author":"C Chiesa","year":"2014","unstructured":"Chiesa C, Lambert B, Maccauro M, Ezziddin S, Ahmadzadehfar H, Dieudonn\u00e9 A, et al. The predictive power of 99mTc-MAA SPECT\/CT on lesion response cannot be invalidated for all kind of lesions and all kind of 90Y microspheres by a barely visual evaluation of the uptake and a RECIST response evaluation of colorectal metastases treated with resin microspheres. J Nucl Med 2014;55(7):1215\u20136.","journal-title":"J Nucl Med"},{"key":"3068_CR46","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2967\/jnumed.112.117614","volume":"54","author":"M Wondergem","year":"2013","unstructured":"Wondergem M, Smits MLJ, Elschot M, de Jong HWAM, Verkooijen HM, van den Bosch MAAJ, et al. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med 2013;54:1294\u2013301.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3068-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3068-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3068-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:25Z","timestamp":1558713985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3068-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,27]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3068-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,27]]}}}